Feasibility and safety of autologous cord blood derived cell administration in extremely preterm infants: a single-centre, open-label, single-arm, phase I trial (CORD-SaFe study)
Funding to support this study was obtained from National Health and Medical Research Council of Australia, Cerebral Palsy Alliance, National Stem Cell Foundation of Australia, and Lions Cord Blood Foundation.
Authors
- Tamara Yawno (ORCID: https://orcid.org/0000-0002-4257-3814)
- Lindsay Zhou (ORCID: https://orcid.org/0000-0002-3013-5040)
- Iona Novak (ORCID: https://orcid.org/0000-0001-6001-4867)
- Graham Jenkin (ORCID: https://orcid.org/0000-0002-7660-1238)
- Courtney McDonald (ORCID: https://orcid.org/0000-0001-8421-461X)
- Suzanne L. Miller
- Abdul Razak (ORCID: https://orcid.org/0000-0002-6108-3183)
- Kristyn Connelly
- Anil K. Malhotra (ORCID: https://orcid.org/0000-0001-9664-4182)
Institutions
- The University of Sydney (AU)
- Hudson Institute of Medical Research (AU)
- Monash Children’s Hospital (AU)
- Monash University (AU)
Publication Details
- Journal
- EBioMedicine
- Published
- 2024-12-13
- DOI
- https://doi.org/10.1016/j.ebiom.2024.105492
- Citations
- 12
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 5.03
Funders
- Hudson Institute of Medical Research
- Cerebral Palsy Alliance
- National Stem Cell Foundation of Australia
- Medical Research Council
- National Health and Medical Research Council